Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

19.59
Delayed Data
As of May 23
 +0.12 / +0.62%
Today’s Change
11.54
Today|||52-Week Range
42.25
-26.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization171.0K175.0K236.0K238.0K
 
 
 
 
 
 
Operating ExpensesGross Income-171.0K-175.0K-236.0K-238.0K
 
 
 
 
 
General Expenses22.8M22.3M30.8M33.1M
 
 
 
 
 
Research And Development16.2M14.2M16.3M16.1M
 
 
 
 
 
Total Operating Expenses23.0M22.5M31.1M33.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.0M-22.5M-31.1M-33.3M
 
 
 
 
 
Interest Expense On Debt237.0K242.0K247.0K133.0K
 
 
 
 
 
Other Expenses144.0K61.0K65.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.1M-22.7M-31.2M-33.4M
 
 
 
 
 
Net Income-23.1M-22.7M-31.2M-33.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.0M35.8M36.0M36.2M
 
 
 
 
 
Shares To Calculate EPS Diluted31.0M35.8M36.0M36.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.74-$0.63-$0.87-$0.92
 
 
 
 
 
EPS Diluted-$0.74-$0.63-$0.87-$0.92